Literature DB >> 11708294

Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

G Eisenhofer1, T T Huynh, M Hiroi, K Pacak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11708294     DOI： 10.1023/a:1011572617314

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  120 in total

1.  A dopamine-secreting pheochromocytoma.

Authors:  K Yasunari; M Kohno; J Yoshikawa
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

2.  Cardiac sympathetic nerve function in congestive heart failure.

Authors:  G Eisenhofer; P Friberg; B Rundqvist; A A Quyyumi; G Lambert; D M Kaye; I J Kopin; D S Goldstein; M D Esler
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

Review 3.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

4.  Kinetics of homovanillic acid and determination of its production rate in humans.

Authors:  M A Elchisak; R J Polinsky; M H Ebert; I J Kopin
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

5.  Sources and physiological significance of plasma dopamine sulfate.

Authors:  D S Goldstein; K J Swoboda; J M Miles; S W Coppack; A Aneman; C Holmes; I Lamensdorf; G Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

6.  Pheochromocytoma in Italy: a multicentric retrospective study.

Authors:  M Mannelli; L Ianni; A Cilotti; A Conti
Journal:  Eur J Endocrinol       Date:  1999-12       Impact factor: 6.664

7.  Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Authors:  G Eisenhofer; M M Walther; T T Huynh; S T Li; S R Bornstein; A Vortmeyer; M Mannelli; D S Goldstein; W M Linehan; J W Lenders; K Pacak
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Norepinephrine metabolism in man using deuterium labeling: turnover 4-hydroxy-3-methoxymandelic acid.

Authors:  G Mårdh; B Sjöquist; E Anggård
Journal:  J Neurochem       Date:  1982-06       Impact factor: 5.372

9.  Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor.

Authors:  T Nakada; I Sasagawa; Y Kubota; H Suzuki; M Ishigooka; M Watanabe
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

10.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Authors:  J W Lenders; G Eisenhofer; N G Abeling; W Berger; D L Murphy; C H Konings; L M Wagemakers; I J Kopin; F Karoum; A H van Gennip; H G Brunner
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808
View more
  34 in total

1.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

Review 2.  Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines.

Authors:  Graeme Eisenhofer; Jacques W M Lenders; Karel Pacak
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

3.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

4.  A Rare Case of Adrenal Pheochromocytoma with Unusual Clinical and Biochemical Presentation: 
A Case Report and Literature Review.

Authors:  Waad-Allah S Mula-Abed; Riyaz Ahmed; Fatima A Ramadhan; Manal K Al-Kindi; Noor B Al-Busaidi; Hilal N Al-Muslahi; Mohammad A Al-Lamki
Journal:  Oman Med J       Date:  2015-09

Review 5.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

6.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

7.  Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?

Authors:  Ryan J Ellis; Dhaval Patel; Tamara Prodanov; Samira Sadowski; Naris Nilubol; Karen Adams; Seth M Steinberg; Karel Pacak; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2013-07-25       Impact factor: 6.113

Review 8.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Authors:  Graeme Eisenhofer; Barbara Klink; Susan Richter; Jacques Wm Lenders; Mercedes Robledo
Journal:  Clin Biochem Rev       Date:  2017-04

Review 9.  Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options.

Authors:  Karren Antonio; Ma Margarita Noreen Valdez; Leilani Mercado-Asis; David Taïeb; Karel Pacak
Journal:  Gland Surg       Date:  2020-02

10.  SubpathwayMiner: a software package for flexible identification of pathways.

Authors:  Chunquan Li; Xia Li; Yingbo Miao; Qianghu Wang; Wei Jiang; Chun Xu; Jing Li; Junwei Han; Fan Zhang; Binsheng Gong; Liangde Xu
Journal:  Nucleic Acids Res       Date:  2009-08-25       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.